https://www.mskcc.org/cancer-care/clinical-trials/23-106
A Phase 2 Study of Selumetinib and Olaparib or Selumetinib Alone for Ovarian and Endometrial...
Full Title A Randomized Trial of Selumetinib and Olaparib or Selumetinib alone in Patients with recurrent or persistent RAS Pathway Mutant Ovarian and...
phase 2 study
https://www.cancer.gov/research/progress/discovery/selumetinib-plexiform-neurofibromas
The Discovery of Selumetinib for Kids with NF1 - NCI
Over 30 years of dedication from scientists at the National Cancer Institute has led to the remarkable discovery of selumetinib as the first effective...
the discoveryfor kidsselumetinibnf1nci
https://medlineplus.gov/druginfo/meds/a620030.html
Selumetinib: MedlinePlus Drug Information
Selumetinib: learn about side effects, dosage, special precautions, and more on MedlinePlus
selumetinibmedlineplusdruginformation
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-selumetinib-non-small-cell-lung-cancer
A study looking at selumetinib for non small cell lung cancer
This study is looking at a new drug called selumetinib for non small cell lung cancer (NSCLC).
a studylooking atsmall cellselumetinib
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-06841&loc=0&q=combomatch&rl=2
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted...
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian...
testingusecombination
https://www.aacr.org/patients-caregivers/progress-against-cancer/expanded-pediatric-use-of-selumetinib-approved-for-inoperable-plexiform-neurofibromas/
Expanded Pediatric Use of Selumetinib for Plexiform Neurofibromas | Research | AACR
Oct 1, 2025 - The FDA expanded the approval of selumetinib to include pediatric patients as young as 1 year with inoperable plexiform neurofibromas.
expandedpediatricuseselumetinibplexiform
https://pocketcasts.com/podcast/jama-editors-summary/ee382a10-f454-012f-a22d-723c91aeae46/selumetinib-for-lung-cancer-postmarket-drug-safety-screening-for-thyroid-cancer-and-more/eaa98aa0-16f7-0135-52f8-452518e2d253
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more -...
May 09, 2017 edition of the weekly JAMA Editors' Summary
lung cancerdrug safetyselumetinibpostmarket
https://www.nice.org.uk/guidance/hst20/chapter/4-Implementation
4 Implementation | Selumetinib for treating symptomatic and inoperable plexiform neurofibromas...
Evidence-based recommendations on selumetinib (Koselugo) for treating symptomatic and inoperable plexiform neurofibromas associated with type 1...
4implementationselumetinibtreatingsymptomatic
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-selumetinib-with-chemotherapy-for-advanced-biliary-tract-cancers-abc04
A trial of selumetinib with chemotherapy for advanced biliary tract cancers (ABC 04)
This trial looked at a drug called selumetinib with chemotherapy for cancer of the bile duct or gallbladder (the biliary tract).
https://www.mayo.edu/research/clinical-trials/cls-20522813
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in...
Learn more about services at Mayo Clinic.
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-azd6244-and-dacarbazine-advanced-melanoma-people-with-braf-gene-fault
A trial of selumetinib with dacarbazine for advanced melanoma in people with a BRAF gene fault
This trial looked at a drug called selumetinib alongside dacarbazine for people with melanoma that has spread to another part of the body.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selumetinib-pediatric-patients-1-year-age-and-older-neurofibromatosis-type-1
FDA approves selumetinib for pediatric patients 1 year of age and older with neurofibromatosis type...
On September 10, 2025, the Food and Drug Administration approved selumetinib (KOSELUGO, AstraZeneca Pharmaceuticals LP) granules and capsules for pediatric...
https://www.mayo.edu/research/clinical-trials/cls-20314931
A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of...
Learn more about services at Mayo Clinic.
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-selumetinib-and-paclitaxel-for-a-type-of-eye-cancer-called-uveal-melanoma-selpac
A trial looking at selumetinib and paclitaxel for a type of eye cancer called uveal melanoma...
This trial is looking at selumetinib and paclitaxel for a type of eye cancer called uveal melanoma.
https://www.merck.com/news/selumetinib-granted-u-s-breakthrough-therapy-designation-in-neurofibromatosis-type-1/
Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1 - Merck.com
Apr 28, 2026 - AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-vandetanib-and-selumetinib-for-solid-tumours-including-nsclc-vansel-1
A trial of vandetanib and selumetinib for solid tumours including non small cell lung cancer...
This trial looked at vandetanib and selumetinib for people who have solid tumours, including non small cell lung cancer.
https://www.cancer.gov/pediatric-adult-rare-tumor/selumetinib-pediatric-tumors-video
Selumetinib shrinks pediatric tumors - NCI
Dr. Brigitte Widemann, leader of MyPART, describes her recent success developing treatment for a rare tumor, plexiform neurofibroma, and how natural history...
selumetinibshrinkspediatrictumorsnci
https://www.mayo.edu/research/clinical-trials/cls-20314931?p=1
A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of...
https://www.mayo.edu/research/clinical-trials/cls-20522813?&p=1
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in...
https://www.healthdirect.gov.au/medicines/medicinal-product/aht,27111/selumetinib
selumetinib | healthdirect
More information is available on selumetinib including side effects, age restrictions, food interactions, whether the medicine is available at a government...
selumetinibhealthdirect
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-selumetinib-docetaxel-non-small-cell-lung-cancer-select-1
A trial of selumetinib and docetaxel for non small cell lung cancer (SELECT-1)
This trial was for people whose non small cell lung cancer had grown into surrounding tissues or spread elsewhere in the body.
non small cell lung cancer